Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.900
+0.090 (4.97%)
At close: Jan 7, 2026, 4:00 PM EST
1.872
-0.028 (-1.48%)
After-hours: Jan 7, 2026, 6:54 PM EST
CMMB's stock price has decreased by -80.53% in the past year and price targets may not have had time to catch up.

Chemomab Therapeutics Analyst Ratings

Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$26.50
Upside
+1,294.74%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Oppenheimer
Oppenheimer
Buy
Maintains
$10$25
BuyMaintains$10$25+1,215.79%Aug 27, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$44$40
BuyMaintains$44$40+2,005.26%May 16, 2025
Maxim Group
Maxim Group
Strong Buy
Maintains
$16$28
Strong BuyMaintains$16$28+1,373.68%Feb 20, 2025
Oppenheimer
Oppenheimer
Buy
Reiterates
$52$44
BuyReiterates$52$44+2,215.79%Nov 15, 2024
Maxim Group
Maxim Group
Strong Buy
Initiates
$16
Strong BuyInitiates$16+742.11%May 13, 2024
Oppenheimer
Oppenheimer
Buy
Upgrades
$24
BuyUpgrades$24+1,163.16%May 6, 2024
Oppenheimer
Oppenheimer
Hold
Maintains
n/a
HoldMaintainsn/an/aMar 8, 2024
Roth MKM
Roth MKM
Strong Buy
Initiates
$28
Strong BuyInitiates$28+1,373.68%Dec 19, 2023
Roth MKM
Roth MKM
Strong Buy
Initiates
$28
Strong BuyInitiates$28+1,373.68%Oct 6, 2023
Oppenheimer
Oppenheimer
Hold
Downgrades
n/a
HoldDowngradesn/an/aJun 7, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$48$28
BuyMaintains$48$28+1,373.68%Apr 18, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$120$80
BuyMaintains$120$80+4,110.53%Mar 10, 2022
Aegis Capital
Aegis Capital
Strong Buy
Initiates
$120
Strong BuyInitiates$120+6,215.79%Dec 7, 2021
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$180
BuyInitiates$180+9,373.68%May 26, 2021
Oppenheimer
Oppenheimer
Buy
Initiates
$168
BuyInitiates$168+8,742.11%May 7, 2021